Post-stroke Delirium in Ischemic Stroke Patients

Ischemic Stroke Clinical Trial

Official title:

Risk Factors and Risk Prediction Model for Post-stroke Delirium in Ischemic Stroke Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06005636
• Other study ID #: KY-2021-106
• Status: Completed
• Start date: September 1, 2021
• Est. completion date: April 27, 2023

Study information

• Verified date: August 2023
• Source: Jinan University Guangzhou
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is to investigate the predictors of post-stroke delirium, develop and validate a nomogram of post-stroke delirium in the ischemic stroke patients.

Description:

Introduction: Post-stroke delirium (PSD) is associated with unfavorable prognosis. Effectively identifying risk factors of PSD and predicting PSD is of essential.

Methods: This is a prospective, single-centered, cohort study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 985
• Est. completion date: April 27, 2023
• Est. primary completion date: September 10, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

1. aged =18 years old;(2) ischemic stroke, confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) scans;(3) patients or their agencies agree to participate in this study.

Exclusion Criteria:

1. brain dysfunction caused by non-vascular causes such as traumatic brain injury, brain tumor or metastatic brain tumor;(2) history of serious mental illness such as schizophrenia;(3) unable to cooperate to the assessment as deafness, blindness, aphasia, dysarthria;(4) be in coma [Glasgow Coma Scale (GCS)=8 points] or sedation [Richmond Agitation Sedation Scale (RASS)<-3 points], and do not ameliorate during study;(5) with incomplete data.

Related Conditions & MeSH terms

• Cerebral Infarction
• Delirium
• Ischemia
• Ischemic Stroke
• Stroke

Intervention

Diagnostic Test:
• Test delirium state
use scale to test whether ischemic stroke patients have post-stroke delirium

Locations

Country	Name	City	State
China	the First Affiliated Hospital of Jinan University	Guangzhou	Guangdong

Sponsors (2)

Lead Sponsor	Collaborator
Jinan University Guangzhou	First Affiliated Hospital of Jinan University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	post-stroke delirium		The first week of admission